We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.51%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.28B
AUM Growth
+$663M
(+41%)
Cap. Flow
+$192M
Cap. Flow
% of AUM
8.42%
Top 10 Holdings %
Top 10 Hldgs %
37.08%
Holding
98
New
19
Increased
31
Reduced
23
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$56.8M |
| 2 |
Biogen
BIIB
|
+$47.5M |
| 3 |
UnitedHealth
UNH
|
+$32.1M |
| 4 |
Lantheus
LNTH
|
+$30.4M |
| 5 |
AutoZone
AZO
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXRT
Vaxart
VXRT
|
+$72M |
| 2 |
Deckers Outdoor
DECK
|
+$30.5M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$29.6M |
| 4 |
Amazon
AMZN
|
+$25.4M |
| 5 |
Dollar Tree
DLTR
|
+$22.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.31% |
| 2 | Consumer Discretionary | 15.79% |
| 3 | Consumer Staples | 9.9% |
| 4 | Technology | 5.31% |
| 5 | Industrials | 3.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Domino's
DPZ
$12.1B
| $15.6M | 0.69% |
42,295
+17,953
| +74% | +$6.61M |
|
52
O'Reilly Automotive
ORLY
$73.3B
| $15.4M | 0.68% |
+549,525
| New | +$14.4M |
|
|
AIMT
53
DELISTED
Aimmune Therapeutics
AIMT
| $15.4M | 0.68% |
924,000
+324,000
| +54% | +$5.5M |
|
54
argenx
ARGX
$52B
| $15.3M | 0.67% |
+68,000
| New | +$12.1M |
|
55
Kohl's
KSS
$2.28B
| $15.3M | 0.67% |
+735,302
| New | +$14.2M |
|
56
Assembly Biosciences
ASMB
$503M
| $13.9M | 0.61% |
49,667
-10,666
| -18% | -$2.49M |
|
57
CRISPR Therapeutics
CRSP
$4.88B
| $13.8M | 0.61% |
188,000
-48,000
| -20% | -$2.81M |
|
|
EGRX
58
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $13.5M | 0.59% |
+282,000
| New | +$14.1M |
|
59
CVS Health
CVS
$134B
| $11.2M | 0.49% |
172,000
-206,000
| -54% | -$13M |
|
|
CLVS
60
DELISTED
Clovis Oncology, Inc.
CLVS
| $10.8M | 0.47% |
+1,600,000
| New | +$12.1M |
|
|
MNK
61
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $10.7M | 0.47% |
40,000
-12,000
| -23% | -$36K |
|
62
Jack in the Box
JACK
$324M
| $10.1M | 0.44% |
+135,703
| New | +$8.36M |
|
63
Elastic
ESTC
$7.15B
| $9.22M | 0.4% |
+100,000
| New | +$7.3M |
|
|
ZEN
64
DELISTED
ZENDESK INC
ZEN
| $8.85M | 0.39% |
100,000
+42,000
| +72% | +$3.23M |
|
65
Kiora Pharmaceuticals
KPRX
$11.5M
| $8.73M | 0.38% |
5,043
| – | – |
|
66
Thermo Fisher Scientific
TMO
$213B
| $8.7M | 0.38% |
24,000
-4,000
| -14% | -$1.34M |
|
|
ADMS
67
DELISTED
Adamas Pharmaceuticals
ADMS
| $7.02M | 0.31% |
2,742,000
| – | – |
|
68
Booking.com
BKNG
$149B
| $6.37M | 0.28% |
+100,000
| New | +$6.09M |
|
|
TTPH
69
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $3.58M | 0.16% |
1,419,507
| – | – |
|
|
ONCT
70
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $3.57M | 0.16% |
+62,836
| New | +$3.54M |
|
71
Carter's
CRI
$1.47B
| $3.41M | 0.15% |
42,201
-172,799
| -80% | -$13.8M |
|
|
TMDI
72
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
| $1.97M | 0.09% |
+2,363,457
| New | +$1.21M |
|
|
ITRM
73
DELISTED
Iterum Therapeutics
ITRM
| $1.5M | 0.07% |
+84,170
| New | +$3.34M |
|
|
VXRT
74
DELISTED
Vaxart
VXRT
| $1.29M | 0.06% |
145,523
-25,054,477
| -99% | -$72M |
|
75
Yatra Online
YTRA
$54.9M
| $1.22M | 0.05% |
+1,800,000
| New | +$1.94M |
|
Similar funds
CRC
RMDI
F
EW
O
PA
DSC
ACM
Armistice Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Armistice Capital held 98 positions worth $2.28B, up 41% from $1.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Armistice Capital deployed $192M of net new capital in Q2 2020, opening 19 new positions and adding to 31 existing holdings. Its largest new stake was Medtronic: 592,000 shares worth $54.3M.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Vaxart, an estimated $72M trimmed.
- Armistice Capital's largest Q2 2020 buy was Medtronic: 592,000 shares worth $54.3M.
- Armistice Capital added most to Biogen in Q2 2020, an estimated $47.5M increase.
- Armistice Capital's biggest Q2 2020 reduction was Vaxart, cutting an estimated $72M.
- Armistice Capital fully exited Deckers Outdoor in Q2 2020, selling an estimated $30.5M.
- Armistice Capital's ten largest holdings make up 37% of its $2.28B portfolio in Q2 2020.
- Armistice Capital opened 19 new positions and closed 19 in Q2 2020.
- Armistice Capital's portfolio value rose 41% quarter-over-quarter to $2.28B.
Based on Armistice Capital's 13F filing for Q2 2020, filed 14 Aug 2020.